Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol

Abstract Background Currently, adjuvant therapy is not recommended for patients with thoracic esophageal squamous cell cancer (TESCC) after radical surgery, and a proportion of these patients go on to develop locoregional recurrence (LRR) within 2 years. Besides, there is no evidence for salvage che...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xiao Chang, Lei Deng, Wenjie Ni, Chen Li, Weiming Han, Lin-rui Gao, Shijia Wang, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang, Nan Bi, Jima Lv, Shugeng Gao, Yousheng Mao, Qi Xue, Zefen Xiao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2020-09-01
coleção:	BMC Cancer
Assuntos:	Esophageal neoplasm Locoregional recurrence R1/R2 resection Chemoradiation therapy Palliative management
Acesso em linha:	http://link.springer.com/article/10.1186/s12885-020-07315-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!